Native PLGA nanoparticles attenuate disease pathology via multiple pathways in 5xFAD Alzheimer's model

Govindarajan Karthivashan, Shuai Wang, Qi Wu, Abhishek Dahal, Xiuju Li, Danny Galleguillos, Simonetta Sipione, Gopal Thinakaran, Satyabrata Kar · 2026

Read Native PLGA nanoparticles attenuate disease pathology via multiple pathways in 5xFAD Alzheimer's model by Govindarajan Karthivashan, Shuai Wang, Qi Wu, Abhishek Dahal, Xiuju Li, Danny Galleguillos, Simonetta Sipione, Gopal Thinakaran, Satyabrata Kar (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13240024.txt.

Description

Govindarajan Karthivashan and co-authors test whether a common drug-carrier material, on its own, can slow Alzheimer's disease in mice. Their 2026 study uses a mouse strain bred to build up amyloid beta, the protein clumps linked to the disease, and treats older mice with steady doses into the brain's fluid spaces.

After treatment, the mice showed better memory scores, lower amyloid levels and deposits, and less nerve cell damage. Gene readouts from brain tissue shifted in pathways tied to waste clearance, cell defense, and immune activity. The authors link the gains to changes in how amyloid is made, cleared, and how cells handle stress. They argue the plain carrier itself may hold promise as a treatment base.

Catalog record

CREATORGovindarajan Karthivashan, Shuai Wang, Qi Wu, Abhishek Dahal, Xiuju Li, Danny Galleguillos, Simonetta Sipione, Gopal Thinakaran, Satyabrata Kar
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE80 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13240024

Browse the full library · About the Tower of Babel